More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$15.25B
EPS
8.19
P/E ratio
10.9
Price to sales
1.83
Dividend yield
--
Beta
0.670494
Previous close
$88.61
Today's open
$88.29
Day's range
$87.92 - $89.65
52 week range
$62.38 - $90
show more
CEO
Bryan C. Hanson
Employees
22000
Headquarters
Eagan, MN
Exchange
New York Stock Exchange
Shares outstanding
170223729
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
Why Solventum (SOLV) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research • Aug 17, 2026

SOLV Plans Health Information Systems Business Spinoff to Drive Growth
Solventum plans to spin off its $1.4B HIS business, sharpening its MedTech focus while giving HIS more flexibility to pursue growth.
Zacks Investment Research • Aug 14, 2026

Here's Why Solventum (SOLV) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research • Aug 10, 2026

Solventum Q2 Earnings Call Highlights
Solventum NYSE: SOLV reported second-quarter results that exceeded its internal expectations, supported by broad-based segment performance, planned order activity ahead of an ERP cutover and a tariff refund benefit. The company also announced plans to separate its Health Information Systems, or HIS, business as part of a broader effort to sharpen its focus on medical technology markets.
MarketBeat • Aug 9, 2026

Solventum Stock Up as Q2 Earnings & Revenues Beat Estimates
SOLV's Q2 earnings and revenues beat estimates as organic sales increase 9.5%, prompting higher 2026 guidance despite ERP timing benefits.
Zacks Investment Research • Aug 6, 2026

Solventum to hive off healthcare software business, raises profit forecast
Solventum , one of the largest providers of hospital consumables and sterilization devices, said on Wednesday it is planning to separate its health information systems business as part of its ongoing turnaround strategy.
Reuters • Aug 5, 2026

Solventum Corporation (SOLV) Q2 2026 Earnings Call Transcript
Solventum Corporation (SOLV) Q2 2026 Earnings Call Transcript
Seeking Alpha • Aug 6, 2026

Solventum Reports Second Quarter 2026 Financial Results
Reported sales increased 2.2%; organic sales increased 9.5% Announces intent to separate its Health Information Systems business segment Increases full-year 2026 guidance for organic sales growth, adjusted EPS and free cash flow EAGAN, Minn., Aug. 5, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) today reported financial results for the second quarter ended June 30, 2026.
PRNewsWire • Aug 5, 2026

Solventum (SOLV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Solventum (SOLV) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks Investment Research • Aug 5, 2026

Solventum (SOLV) Q2 Earnings and Revenues Top Estimates
Solventum (SOLV) came out with quarterly earnings of $2.55 per share, beating the Zacks Consensus Estimate of $1.91 per share. This compares to earnings of $1.69 per share a year ago.
Zacks Investment Research • Aug 5, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Solventum Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.